Insmed Incorporated (IM8N.SG)
Insmed Incorporated develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.
88.94+0.02%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-4.9%
The outlook
Insmed Incorporated currently reads as bearish based on below its 50- & 200-day averages, 10% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range10% of the way from its 52-week low to high
Market cap
$19.28B
52-wk high
184.00
52-wk low
78.79
50-day avg
91.26
200-day avg
126.20
Trailing P/E
—